Gladius Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,265
| Closed | -$36.6K | – | 327 |
|
|
2023
Q4 | $36.6K | Buy |
1,265
+310
| +32% | +$8.97K | 0.01% | 153 |
|
|
2023
Q3 | $26.3K | Buy |
955
+240
| +34% | +$6.62K | ﹤0.01% | 231 |
|
|
2023
Q2 | $21.5K | Buy |
+715
| New | +$21.5K | ﹤0.01% | 212 |
|
|
2023
Q1 | – | Sell |
-1,019
| Closed | -$36.3K | – | 344 |
|
|
2022
Q4 | $36.3K | Sell |
1,019
-25
| -2% | -$892 | ﹤0.01% | 208 |
|
|
2022
Q3 | $36K | Buy |
+1,044
| New | +$36K | ﹤0.01% | 187 |
|